Psychoactive drug advertising
a comparison of technical information from three countries: Brazil, United States and United Kingdom
Keywords:
Pharmaceutical preparations, Propaganda, Advertising, Psychotropic drugs, LegislationAbstract
CONTEXT AND OBJECTIVE: Studies carried out in the 1970s and 1980s showed that there were country-dependent disparities in the information given for the same drug in medical advertise- ments. National and international regulations have been published to do away with such dis- parities and to foster the rational use of drugs. The purpose of this study was to compare the informa- tion contained in psychoactive drug advertise- ments published in psychiatric journals in Brazil, the United States and the United Kingdom, before and subsequent to the publication of the United States Export Act, in 1986, the WHO criteria, in 1988, and the Brazilian Sanitary Surveillance Agency Resolution no. 102, in 2000. TYPE OF STUDY AND SETTING: Content analysis, at Centro Brasileiro de Informações sobre Drogas Psicotrópicas (Cebrid). METHODS: We gathered advertisements from Brazilian, American and British psychiatry periodi- cals published before and after each ruling. We analyzed a total of twenty-four Brazilian advertise- ments that were for the same psychoactive drugs as advertised in American and/or British publications from the same period. RESULTS: We observed that Brazilian advertise- ments omitted information on usage restrictions, such as contraindications, adverse reactions, interactions, warnings and precautions, and that such information was present in American and British advertisements. CONCLUSIONS: The data suggest that disparities in the information given for the same drug still persist. The information depends on the country in which each drug is marketed. The legislation is insufficient for eradicating such disparities.
Downloads
References
Kessler DA, Pines WL. The federal regulation of prescription drug advertising and promotion. JAMA. 1990;264(18):2409-15.
Hogerzeil HV. Promoting rational prescribing: an international perspective. Br J Clin Pharmacol. 1995;39(1):1–6.
Organización Mundial de la Salud (OMS). Criterios éticos para la promoción de medicamentos. Genebra: Organización Mundial de la Salud (OMS);1988. Available from URL: http://www.minsa.gob.pe/infodigemid/normatividad/criteri-oms.htm. Accessed in 2005 (Jun 7).
U. S. Congress, Office of Technology Assessment. Drug labeling in developing countries. Washington: Government Printing Office; 1993. Available from URL: http://www.wws.princeton.edu/cgi-bin/byteserv.prl/~ota/disk1/1993/9321/9321.PDF. Accessed in 2005 (Jun 7).
Herxheimer A, Lundborg CS, Westerholm B. Advertisements for medicines in leading medical journals in 18 countries: a 12-month survey of information content and standards. Int J Health Serv. 1993;23(1):161-72.
Brasil. Ministério da Saúde. Agência Nacional de Vigilância Sanitária. Lei no 6360, de 23 de setembro de 1976 (Versão Consolidade pela Procuradoria da ANVISA). Dispõe sobre a vigilância sanitária a que ficam sujeitos os medicamentos, as dro- gas, os insumos farmacêuticos e correlatos, cosméticos, saneantes e outros produtos, e dá outras providências. D.O.U. – Diário Oficial da União; Poder Executivo, de 24 de setembro de 1976. Available from URL: http://e-legis.bvs.br/leisref/public/search. php. Accessed in 2005 (Aug 2)
Brasil. Ministério da Saúde. Agência Nacional de Vigilância San- itária. Lei no 9294, de 15 de julho de 1996 (Versão Consolidada pela Procuradoria da ANVISA). Dispõe sobre as restrições ao uso e à propaganda de produtos fumígeros, bebidas alcoólicas, medicamentos, terapias e defensivos agrícolas, nos termos do § 4° do art. 220 da Constituição Federal. D.O.U. - Diário Oficial da União; Poder Executivo, de 16 de julho de 1996. Available from URL: http://e-legis.bvs.br/leisref/public/search.php. Accessed in 2005 (Aug 2).
Brasil. Ministério da Saúde. Agência Nacional de Vigilância Sanitária. Resolução RDC no 102, de 30 de novembro de 2000. Aprova o Regulamento sobre propagandas, mensagens publicitarias e promocionais e outras práticas cujo objeto seja a divulgação, promoção ou comercialização de medicamentos de produção nacional ou importados, quaisquer que sejam as formas e meios de sua veiculação, incluindo as transmitidas no decorrer da programação normal das emissoras de rádio ë televisão.
D. O. U. Diário Oficial da União; Poder Executivo, de 01 de dezembro de 2000. Available from URL: http://e-legis.bvs.br/leis-ref/public/showAct.php?id=11079. Accessed in 2005 (Jun 7).
Saporito R, Goldberg R. The changing image of prescription drug advertisements. J Drug Education. 1982;12(4):365-72.
Carlini EA. Utilização de medicamentos. Instituto de Quali- dade/Fundação Oswaldo Cruz/Ministério da Saúde/Boletim de Informações. 1981;I(4):70-99.
Carlini EA. O uso e a propaganda de medicamentos. Exemplos com psicotrópicos. Rev Ass Bras Psiq. 1983;5:152-8.
Hemminki E. The quality of drug advertisements in two Finnish medical journals. A comparison between psychotropic and other drug advertisements. Soc Sci Med. 1973;7(1):51-9.
Alloza JL, Lasagna L. A comparison of drug product infor- mation in four national compendia. Clin Pharmacol Ther. 1983;33(3):269-77.
Barros JAC. A (des)informação sobre medicamentos: o duplo pa- drão de conduta das empresas farmacêuticas. [(Mis)information on drugs: the double standard practiced by pharmaceutical companies]. Cad Saúde Pública. 2000;16(2):421–7.
National Library of Medicine. Journals. Available from URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=journals. Accessed in 2005 (Aug 2).
Biblioteca Virtual em Saúde. Pesquisa em bases de dados. LILACS. Available from URL: http://bases.bireme.br/cgi-bin/xislind.exe/iah/online/. Accessed in 2005 (Aug 2).
Pan American Health Organization. Available from URL: http://www.paho.org/. Accessed in 2005 (Aug 2).
Minayo MCS. O desafio do conhecimento: pesquisa qualitativa em saúde. 2a ed. São Paulo: Hucitec; 1998.
Bardin L. Análise de conteúdo. Lisboa: Edições 70; 1977.
Silverman M. The epidemiology of drug promotion. Int J Health Serv. 1977;7(2):157-66.
Silverman M, Lee PR, Lydecker M. The drugging of the Third World. Int J Health Serv. 1982;12(4):585-96.
Silverman M, Lee PR, Lydecker M. Drug promotion: the Third World revisited. Int J Health Serv. 1986;16(4):659-67.
Lee PR, Lurie P, Silverman MM, Lydecker M. Drug promo- tion and labeling in developing countries: an update. J Clin Epidemiol. 1991;44(Suppl 2):49S–55S.
Chetley A. 1A. Introduction. What is a problem drug? In: Chetley A, editor. Problem Drugs. Amsterdam: Health Action International; 1993. p. 1-8.
Cooper JW. Reducing psychotropic drugs reduces falls in elderly people. BMJ. 2001;323(7309):402.
Kleinman DL, Cohen LJ. The decontextualization of mental illness: the portrayal of work in psychiatric drug advertisements. Soc Sci Med. 1991;32(8):867-74.
Wilkes MS, Doblin BH, Shapiro MF. Pharmaceutical advertise- ments in leading medical journals: experts’ assessments. Ann Intern Med. 1992;116(11):912-9.
Carandang ED, Moulds RF. Pharmaceutical advertisements in Australian medical publications – have they improved? Med J Aust. 1994;161(11-12):671-2.
Jaillon P. The control of prescription drug advertising: a con- troversial issue. Clin Pharmacol Ther. 2000;68(6):583-5.
Chadduck HW. ‘In Brief Summary’: Prescription drug advertising, 1962-71. Washington: FDA Health Action International; 1972.
Smith MC. Drug product advertising and prescribing: a review of the evidence. Am J Hosp Pharm. 1977;34(11):1208-24.
Kessler DA. Addressing the problem of misleading advertising. Ann Intern Med. 1992;116(11):950-1.
Lexchin J. Pharmaceutical promotion in the third world. J Drug Issues. 1992;22(2):417-53.
Lexchin J, Holbrook A. Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal. CMAJ. 1994;151(1):47-54.
Lexchin J. How patient outcomes are reported in drug advertise- ments. Can Fam Physician. 1999;45:1213-6.
Hayes TA. The Food and Drug Administration’s regulation of drug labeling, advertising, and promotion: looking back and looking ahead. Clin Pharmacol Ther. 1998;63(6):607-16.
Bell RA, Wilkes MS, Kravitz RL. The educational value of consumer-targeted prescription drug print advertising. J Fam Pract. 2000;49(12):1092-8.
Gutknecht DR. Evidence-based advertising? A survey of four major journals. J Am Board Fam Pract. 2001;14(3):197–200.
Madridejos R, Cabezas C, Flor F. Publicidad de medicamentos en las revistas médicas. [Drug advertising in medical journals]. Aten Primaria. 1996;17(6):408-10
